Insulet Operating Income from 2010 to 2026

PODD Stock

USD 242.74 1.92 0.80%

Insulet's Operating Income is increasing over the years with slightly volatile fluctuation. Overall, Operating Income is expected to go to about 373 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Insulet generates from its operations. View All Fundamentals

Operating Income

First Reported

2005-03-31

Previous Quarter

121.1 M

Current Value

117.7 M

Quarterly Volatility

33 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Insulet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insulet's main balance sheet or income statement drivers, such as Interest Expense of 51.6 M, Other Operating Expenses of 2.1 B or Operating Income of 373 M, as well as many indicators such as Price To Sales Ratio of 15.94, Dividend Yield of 0.0 or PTB Ratio of 19.9. Insulet financial statements analysis is a perfect complement when working with Insulet Valuation or Volatility modules.

Build AI portfolio with Insulet Stock

Check out the analysis of Insulet Correlation against competitors.

For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

Analyzing Insulet's Operating Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Income has evolved provides context for assessing Insulet's current valuation and future prospects.

Latest Insulet's Operating Income Growth Pattern

Below is the plot of the Operating Income of Insulet over the last few years. Operating Income is the amount of profit realized from Insulet operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Insulet is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Insulet's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insulet's overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Insulet Operating Income Regression Statistics

	Arithmetic Mean	79,428,574
	Geometric Mean	50,158,380
	Coefficient Of Variation	181.32
	Mean Deviation	115,998,692
	Median	27,423,000
	Standard Deviation	144,023,174
	Sample Variance	20742.7T
	Range	421.7M
	R-Value	0.87
	Mean Square Error	5491T
	R-Squared	0.75
	Slope	24,729,794
	Total Sum of Squares	331882.8T

Insulet Operating Income History

	2026	373 M
	2025	355.2 M
	2024	308.9 M
	2023	220 M
	2022	37.6 M
	2021	126 M
	2020	51.5 M

Other Fundumenentals of Insulet

Non Operating Income Net Other

Insulet Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Total Current Assets	Short Term Debt	Current Deferred Revenue	Retained Earnings	Accounts Payable	Common Stock	Long Term Debt	Net Receivables	Short Term Investments	Property Plant Equipment	Net Tangible Assets	Good Will	Long Term Debt Total	Capital Surpluse	Intangible Assets	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	0.77	0.99	1.0	0.08	0.86	0.56	0.32	0.72	0.96	0.96	0.09	0.97	0.86	0.82	0.97	0.79	0.9	-0.39	0.88	0.89	0.9
Total Stockholder Equity	0.96		0.6	0.9	0.97	0.07	0.81	0.7	0.16	0.59	0.86	0.95	-0.01	0.87	0.8	0.75	0.88	0.69	0.91	-0.32	0.89	0.88	0.8
Net Debt	0.77	0.6		0.84	0.73	-0.03	0.8	0.21	0.34	0.69	0.86	0.75	0.32	0.84	0.6	0.76	0.85	0.62	0.69	-0.49	0.61	0.6	0.76
Total Liab	0.99	0.9	0.84		0.98	0.08	0.87	0.45	0.41	0.78	0.99	0.93	0.15	0.99	0.86	0.83	1.0	0.82	0.86	-0.43	0.85	0.87	0.93
Total Current Assets	1.0	0.97	0.73	0.98		0.09	0.85	0.55	0.32	0.72	0.96	0.95	0.07	0.96	0.88	0.8	0.97	0.8	0.89	-0.37	0.88	0.91	0.9
Short Term Debt	0.08	0.07	-0.03	0.08	0.09		0.02	-0.07	0.03	0.02	0.1	0.06	0.41	-0.01	0.04	0.14	0.09	0.15	-0.03	0.73	0.03	0.02	-0.07
Current Deferred Revenue	0.86	0.81	0.8	0.87	0.85	0.02		0.53	0.11	0.62	0.83	0.89	-0.05	0.84	0.67	0.82	0.84	0.57	0.92	-0.36	0.8	0.78	0.78
Retained Earnings	0.56	0.7	0.21	0.45	0.55	-0.07	0.53		-0.39	-0.01	0.36	0.68	-0.27	0.42	0.29	0.32	0.41	0.08	0.78	-0.15	0.63	0.55	0.39
Accounts Payable	0.32	0.16	0.34	0.41	0.32	0.03	0.11	-0.39		0.69	0.5	0.09	0.33	0.49	0.49	0.25	0.47	0.62	-0.02	-0.42	0.2	0.26	0.58
Common Stock	0.72	0.59	0.69	0.78	0.72	0.02	0.62	-0.01	0.69		0.81	0.61	0.17	0.8	0.7	0.79	0.79	0.83	0.5	-0.48	0.72	0.75	0.84
Long Term Debt	0.96	0.86	0.86	0.99	0.96	0.1	0.83	0.36	0.5	0.81		0.88	0.19	0.99	0.88	0.81	1.0	0.86	0.8	-0.44	0.81	0.85	0.94
Net Receivables	0.96	0.95	0.75	0.93	0.95	0.06	0.89	0.68	0.09	0.61	0.88		0.03	0.89	0.72	0.82	0.89	0.63	0.96	-0.33	0.88	0.85	0.81
Short Term Investments	0.09	-0.01	0.32	0.15	0.07	0.41	-0.05	-0.27	0.33	0.17	0.19	0.03		0.12	-0.05	0.2	0.18	0.17	-0.15	0.26	-0.03	-0.16	0.04
Property Plant Equipment	0.97	0.87	0.84	0.99	0.96	-0.01	0.84	0.42	0.49	0.8	0.99	0.89	0.12		0.88	0.79	0.99	0.83	0.83	-0.54	0.83	0.86	0.96
Net Tangible Assets	0.86	0.8	0.6	0.86	0.88	0.04	0.67	0.29	0.49	0.7	0.88	0.72	-0.05	0.88		0.62	0.88	0.92	0.69	-0.46	0.74	0.86	0.83
Good Will	0.82	0.75	0.76	0.83	0.8	0.14	0.82	0.32	0.25	0.79	0.81	0.82	0.2	0.79	0.62		0.8	0.72	0.72	-0.27	0.83	0.78	0.73
Long Term Debt Total	0.97	0.88	0.85	1.0	0.97	0.09	0.84	0.41	0.47	0.79	1.0	0.89	0.18	0.99	0.88	0.8		0.84	0.83	-0.44	0.83	0.86	0.94
Capital Surpluse	0.79	0.69	0.62	0.82	0.8	0.15	0.57	0.08	0.62	0.83	0.86	0.63	0.17	0.83	0.92	0.72	0.84		0.52	-0.38	0.73	0.82	0.8
Intangible Assets	0.9	0.91	0.69	0.86	0.89	-0.03	0.92	0.78	-0.02	0.5	0.8	0.96	-0.15	0.83	0.69	0.72	0.83	0.52		-0.38	0.86	0.84	0.77
Short Long Term Debt	-0.39	-0.32	-0.49	-0.43	-0.37	0.73	-0.36	-0.15	-0.42	-0.48	-0.44	-0.33	0.26	-0.54	-0.46	-0.27	-0.44	-0.38	-0.38		-0.39	-0.41	-0.57
Net Invested Capital	0.88	0.89	0.61	0.85	0.88	0.03	0.8	0.63	0.2	0.72	0.81	0.88	-0.03	0.83	0.74	0.83	0.83	0.73	0.86	-0.39		0.95	0.83
Net Working Capital	0.89	0.88	0.6	0.87	0.91	0.02	0.78	0.55	0.26	0.75	0.85	0.85	-0.16	0.86	0.86	0.78	0.86	0.82	0.84	-0.41	0.95		0.86
Capital Stock	0.9	0.8	0.76	0.93	0.9	-0.07	0.78	0.39	0.58	0.84	0.94	0.81	0.04	0.96	0.83	0.73	0.94	0.8	0.77	-0.57	0.83	0.86

Click cells to compare fundamentals

About Insulet Financial Statements

Insulet stakeholders use historical fundamental indicators, such as Insulet's Operating Income, to determine how well the company is positioned to perform in the future. Although Insulet investors may analyze each financial statement separately, they are all interrelated. For example, changes in Insulet's assets and liabilities are reflected in the revenues and expenses on Insulet's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Insulet. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	355.2 M	373 M
Non Operating Income Net Other	-1.3 M	-1.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether Insulet is a strong investment it is important to analyze Insulet's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insulet's future performance. For an informed investment choice regarding Insulet Stock, refer to the following important reports:

How To Invest In Insulet

Details

Is Insulet Stock a good investment?

Details

What is Insulet's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Insulet Correlation against competitors.

For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.

You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Will Health Care Equipment & Supplies sector continue expanding? Could Insulet diversify its offerings? Factors like these will boost the valuation of Insulet. Anticipated expansion of Insulet directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Insulet data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Quarterly Earnings Growth

0.148

Earnings Share

3.42

Revenue Per Share

35.873

Quarterly Revenue Growth

0.299

Return On Assets

0.0874

Understanding Insulet requires distinguishing between market price and book value, where the latter reflects Insulet's accounting equity. The concept of intrinsic value - what Insulet's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Insulet's price substantially above or below its fundamental value.

It's important to distinguish between Insulet's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Insulet should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Insulet's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Insulet Operating Income from 2010 to 2026

Latest Insulet's Operating Income Growth Pattern

Insulet Operating Income Regression Statistics

Insulet Operating Income History

Other Fundumenentals of Insulet

Insulet Operating Income component correlations

About Insulet Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY